Literature DB >> 21764151

Severe frailty and cognitive impairment are related to higher mortality in 12-month follow-up of nursing home residents.

Paweł Matusik1, Krzysztof Tomaszewski, Katarzyna Chmielowska, Jan Nowak, Wojciech Nowak, Agnieszka Parnicka, Marzena Dubiel, Jerzy Gąsowski, Tomasz Grodzicki.   

Abstract

Frailty syndrome (FS) and cognitive impairment are associated with an increased risk of falls, disability, hospitalization and death. We investigated prognostic meaning of FS and cognitive impairment in persons ≥ 65 years, living in 2 nursing homes. Information about the health status of patients was gathered from history, medical documentation, test assessing FS, according to the Canadian Study of Health and Aging-Clinical Frailty Scale (CSHA-CFS) and the Mini-Mental State Examination (MMSE). The study group included 66 women and 20 men, between 66 and 101 years of age (mean ± S.D.=83.8 ± 8.3 years). The frequency of severe frailty (CSHA-CFS=7) among the elderly living in nursing homes was 34.9%, while severe cognitive impairment (MMSE<18) was present in 55.8%. Residents with severe FS and MMSE<18 consisted 33.7% of examined and 50.0% of those who died during 12-month follow-up, p<0.05. Individuals with severe FS and severe cognitive impairment (n=29) as compared to all other patients, were significantly less probable (59% vs. 79%, p=0.03) to survive one year. Neither frailty, nor dementia, nor severe FS or cognitive impairment when considered separately was associated with higher mortality rate. The risk assessment in severely disabled geriatric patients is best performed with measures of functional and cognitive function considered jointly, but not separately.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21764151     DOI: 10.1016/j.archger.2011.06.034

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  25 in total

1.  Behavioral management in the person with dementia.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

2.  FRAIL-NH Predicts Outcomes in Long Term Care.

Authors:  E W Kaehr; L C Pape; T K Malmstrom; J E Morley
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

3.  Nutritional Status is Associated With Severe Dementia and Mortality: The Cache County Dementia Progression Study.

Authors:  Chelsea L Sanders; Heidi J Wengreen; Sarah Schwartz; Stephanie J Behrens; Chris Corcoran; Constantine G Lyketsos; JoAnn T Tschanz
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

4.  Cognitive function and 10 year mortality in an 85 year-old community-dwelling population.

Authors:  Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Sumio Akifusa; Kenichi Goto; Akihiro Yoshida; Hiroki Fujii; Ritsuko Fujisawa; Kazuo Sonoki
Journal:  Clin Interv Aging       Date:  2014-10-07       Impact factor: 4.458

5.  Burden of frailty in the elderly population: perspectives for a public health challenge.

Authors:  Fanny Buckinx; Yves Rolland; Jean-Yves Reginster; Céline Ricour; Jean Petermans; Olivier Bruyère
Journal:  Arch Public Health       Date:  2015-04-10

6.  Relationship between cognition and frailty in elderly: A systematic review.

Authors:  Allan Gustavo Brigola; Estefani Serafim Rossetti; Bruna Rodrigues Dos Santos; Anita Liberalesso Neri; Marisa Silvana Zazzetta; Keika Inouye; Sofia Cristina Iost Pavarini
Journal:  Dement Neuropsychol       Date:  2015 Apr-Jun

7.  Validation of the revised 9-scale clinical frailty scale (CFS) in Greek language.

Authors:  Ioannis Vrettos; Panagiota Voukelatou; Stefani Panayiotou; Andreas Kyvetos; Andreas Kalliakmanis; Konstantinos Makrilakis; Petros P Sfikakis; Dimitris Niakas
Journal:  BMC Geriatr       Date:  2021-06-29       Impact factor: 3.921

8.  Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.

Authors:  Samuel Golpanian; Darcy L DiFede; Marietsy V Pujol; Maureen H Lowery; Silvina Levis-Dusseau; Bradley J Goldstein; Ivonne H Schulman; Bangon Longsomboon; Ariel Wolf; Aisha Khan; Alan W Heldman; Pascal J Goldschmidt-Clermont; Joshua M Hare
Journal:  Oncotarget       Date:  2016-03-15

9.  Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort.

Authors:  F Buckinx; J Y Reginster; T Brunois; C Lenaerts; C Beaudart; J L Croisier; J Petermans; O Bruyère
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-09-01       Impact factor: 2.041

10.  Multi-dimensional frailty and its risk factors among older residents in long-term care facilities in Shanghai, China.

Authors:  Huihui Wang; Jing Wang; Boqin Xie; Bangzhong Liu; Junqiao Wang
Journal:  Int J Nurs Sci       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.